Curiouser and curiouser: recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles.
about
Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice are susceptible to intracerebral thrombosis and ischemic stroke.Reduced fibrinogen, fibrinolytic biomarkers, and physical parameters after a weight-loss program in obese subjectsAssessment of thrombin-activatable fibrinolysis inhibitor (TAFI) activation in acquired hemostatic dysfunction: a diagnostic challengeTargeted modulation of reactive oxygen species in the vascular endotheliumCarboxypeptidase N-deficient mice present with polymorphic disease phenotypes on induction of experimental autoimmune encephalomyelitis.Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?Data supporting the structural and functional characterization of Thrombin-Activatable Fibrinolysis Inhibitor in breast cancerEndothelial targeting of antibody-decorated polymeric filomicelles.Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis.Type 2 diabetes as a modifier of fibrin clot properties in patients with coronary artery disease.Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in menInsights into thrombin activatable fibrinolysis inhibitor function and regulation.Activated thrombin-activatable fibrinolysis inhibitor attenuates the angiogenic potential of endothelial cells: potential relevance to the breast tumour microenvironment.Dose-Response Relationship Between Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) and Stroke: A Chinese Case-Control Study.Secretion and antifibrinolytic function of thrombin-activatable fibrinolysis inhibitor from human platelets.Convalescent plasma levels of TAFI activation peptide predict death and recurrent vascular events in ischemic stroke survivors.Thrombin activatable fibrinolysis inhibitor : its role in slow coronary flow.Thrombin Activable Fibrinolysis Inhibitor in Beta Thalassemia.Plasma levels of carboxypeptidase U (CPU, CPB2 or TAFIa) are elevated in patients with acute myocardial infarction
P2860
Q33640335-D6560768-32A5-4AAF-B51E-C51D8DE843EEQ34153366-6EC1BFAD-D4F2-4707-84BD-8B16F2F454D0Q34501046-CFB60213-5DDA-43DF-879E-A698C8D65D04Q35098774-B15898F7-03D3-484D-AFED-B570AF4C1CE3Q35116383-572AB619-F5BB-4F0B-B650-3E52E9C46FC3Q35208114-09553438-B0BD-4C6B-AB37-3E75FBCDC350Q35887881-F39CA97B-8548-4AB3-840C-BFF6CF8A7155Q35930068-03814CEA-ED10-4A78-965E-31A91FA420A5Q36028684-1D8FFE68-F50F-488A-ACA0-F69AC5AC8B29Q36546041-D3DA570C-E779-415A-83AF-0006C2D1F44CQ37207774-62393EDB-D7B2-4D95-BE2A-19178A97B569Q38117742-127BB9BC-B4F1-4886-A204-F01EEABABD4AQ38719374-2D2538E3-93DC-4FEB-93BD-FE674D819C4DQ40048594-038C545E-5B99-400F-BA00-54D15F2FFC8EQ42932507-D98856E1-1386-449C-9C8B-0991C89E3BCDQ44739646-6A009C5E-70BF-47BE-B18B-59A396EFA525Q44935309-CD15E26B-287A-4139-9097-4CC6A8BF43F8Q51596755-0AF659F5-502C-4D21-90D4-72FA832EEAD7Q58864163-196F6A59-2826-4160-8CEE-EF76146027AB
P2860
Curiouser and curiouser: recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Curiouser and curiouser: recen ...... ulation, and biological roles.
@en
type
label
Curiouser and curiouser: recen ...... ulation, and biological roles.
@en
prefLabel
Curiouser and curiouser: recen ...... ulation, and biological roles.
@en
P1476
Curiouser and curiouser: recen ...... ulation, and biological roles.
@en
P2093
Marlys L Koschinsky
Michael B Boffa
P304
P356
10.1016/J.CLINBIOCHEM.2006.10.020
P577
2006-11-21T00:00:00Z